A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 5 X users
patent: 1 patent

Readers on

mendeley: 66 Mendeley

Summary News Blogs X Patents

So far, Altmetric has seen 1 patent that references this research output.

METHOD FOR TREATING INFECTIONS WITH OX40 RECEPTOR AGONISTS/BLOCKERS

Application WO-2022055399-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.